— Nuance Communications Inc. (NASDAQ: NUAN) reported its fourth-quarter 2019 adjusted earnings of $0.34 per share under ASC 605 methodology versus $0.28 per share expected.
— Total revenues rose by 2% to $487.8 million versus $485.5 million expected. Adjusted revenue rose by 1.5% to $489.3 million.
— Organic revenue growth of 2% compared to the same period last year.
— Recurring revenue of $376.9 million, up 650 basis points year over year.
— Looking ahead into fiscal 2020, the company expects a continuation of the favorable business trends. Adjusted revenue is predicted to be $1.495-1.535 billion under ASC 606 methodology.
— Adjusted earnings are anticipated to be in the range of $0.80 to $0.88 per share for fiscal 2020 under ASC 606 methodology.
Neurological and neurodegenerative diseases affect a vast segment of the population worldwide and there is a significant demand for treatments for these conditions. Biogen (BIIB) has a strong portfolio of
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in North American sales. Meanwhile, earnings
Goldman Sachs (GS) exceeded analysts’ expectations, as investment banking revenue surged nearly 90%. Goldman market research report covers key aspects about the firm including company profile, financial highlights and key